CA2471964A1 - Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera - Google Patents

Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera Download PDF

Info

Publication number
CA2471964A1
CA2471964A1 CA002471964A CA2471964A CA2471964A1 CA 2471964 A1 CA2471964 A1 CA 2471964A1 CA 002471964 A CA002471964 A CA 002471964A CA 2471964 A CA2471964 A CA 2471964A CA 2471964 A1 CA2471964 A1 CA 2471964A1
Authority
CA
Canada
Prior art keywords
phenyl
hydrogen
methyl
indol
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002471964A
Other languages
English (en)
French (fr)
Inventor
John R. Fozard
Eckhard Weber
Hans-Juergen Pfannkuche
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2471964A1 publication Critical patent/CA2471964A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
CA002471964A 2002-02-08 2003-02-07 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera Abandoned CA2471964A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB0203061.7 2002-02-08
GBGB0203061.7A GB0203061D0 (en) 2002-02-08 2002-02-08 Organic compounds
PCT/EP2003/001227 WO2003066062A1 (en) 2002-02-08 2003-02-07 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera

Publications (1)

Publication Number Publication Date
CA2471964A1 true CA2471964A1 (en) 2003-08-14

Family

ID=9930743

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002471964A Abandoned CA2471964A1 (en) 2002-02-08 2003-02-07 Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera

Country Status (18)

Country Link
US (2) US20050203164A1 (cg-RX-API-DMAC10.html)
EP (2) EP1476167A1 (cg-RX-API-DMAC10.html)
JP (2) JP2005516994A (cg-RX-API-DMAC10.html)
KR (2) KR20040081492A (cg-RX-API-DMAC10.html)
CN (1) CN1301714C (cg-RX-API-DMAC10.html)
AU (1) AU2003244446B2 (cg-RX-API-DMAC10.html)
BR (1) BR0307479A (cg-RX-API-DMAC10.html)
CA (1) CA2471964A1 (cg-RX-API-DMAC10.html)
GB (1) GB0203061D0 (cg-RX-API-DMAC10.html)
IL (2) IL162816A0 (cg-RX-API-DMAC10.html)
MX (1) MXPA04007640A (cg-RX-API-DMAC10.html)
NO (1) NO20043735L (cg-RX-API-DMAC10.html)
NZ (1) NZ534231A (cg-RX-API-DMAC10.html)
PL (1) PL370255A1 (cg-RX-API-DMAC10.html)
RU (1) RU2353356C2 (cg-RX-API-DMAC10.html)
TW (1) TWI330177B (cg-RX-API-DMAC10.html)
WO (1) WO2003066062A1 (cg-RX-API-DMAC10.html)
ZA (1) ZA200404960B (cg-RX-API-DMAC10.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds
AU2004283038B9 (en) * 2003-10-27 2008-04-24 Novartis Ag Use of neurokinin antagonists in the treatment of urinary incontinence
JP2010502736A (ja) 2006-09-08 2010-01-28 オレ・ファーマシューティカルズ・インコーポレーテッド 消化管の炎症を低減または軽減するための方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5217996A (en) * 1992-01-22 1993-06-08 Ciba-Geigy Corporation Biaryl substituted 4-amino-butyric acid amides
US5457101A (en) * 1994-06-03 1995-10-10 Eli Lilly And Company Thieno[1,5]benzoidiazepine use
DE69602087T2 (de) * 1995-02-22 1999-09-09 Novartis Ag 1-aryl-2-acylamino-ethan-verbindungen und ihre verwendung als neurokinin- insbesondere als neurokinin-1-antagonisten
CR5278A (es) * 1995-03-24 1996-07-04 Lilly Co Eli Formulacion oral de 2-metil-tieno-benzodiacepina
GB9525296D0 (en) * 1995-12-11 1996-02-07 Merck Sharp & Dohme Therapeutic agents
MY132550A (en) * 1996-08-22 2007-10-31 Novartis Ag Acylaminoalkenylene-amide derivatives as nk1 and nk2 antogonists
GB9708484D0 (en) * 1997-04-25 1997-06-18 Merck Sharp & Dohme Therapeutic agents
PL191496B1 (pl) * 1997-07-02 2006-05-31 Merck & Co Inc Odmiana polimorficzna 2-(R)-{1-(R) -[3,5-bis(trifluorometylo)-fenylo]etoksy} -3-(S)-(4-fluoro) fenylo-4-[3-(5-okso-1H,4H-1,2,4-triazolo)metylo] morfoliny, sposób jej wytwarzania, zawierająca ją kompozycja farmaceutyczna i jej zastosowanie
TW520370B (en) * 1998-11-20 2003-02-11 Meiji Seika Kaisha Benzooxazole derivatives and a pharmaceutical composition containing the derivatives as an active ingredient
RU2161894C1 (ru) * 1999-08-10 2001-01-20 НИФ "Ультрасан" Лечебно-профилактическая композиция
GB0010958D0 (en) 2000-05-05 2000-06-28 Novartis Ag Organic compounds
CA2432543A1 (en) * 2000-12-22 2002-07-04 Takeda Chemical Industries, Ltd. Combination drugs
GB0203061D0 (en) * 2002-02-08 2002-03-27 Novartis Ag Organic compounds

Also Published As

Publication number Publication date
US20070293473A1 (en) 2007-12-20
JP2010241835A (ja) 2010-10-28
NZ534231A (en) 2007-02-23
BR0307479A (pt) 2004-12-07
KR20040081492A (ko) 2004-09-21
CN1301714C (zh) 2007-02-28
TW200302818A (en) 2003-08-16
HK1077749A1 (en) 2006-02-24
KR20100100994A (ko) 2010-09-15
IL162816A (en) 2010-11-30
US20050203164A1 (en) 2005-09-15
AU2003244446B2 (en) 2006-08-10
PL370255A1 (en) 2005-05-16
ZA200404960B (en) 2006-05-31
EP2216025A3 (en) 2010-11-10
IL162816A0 (en) 2005-11-20
AU2003244446A1 (en) 2003-09-02
EP1476167A1 (en) 2004-11-17
CN1627947A (zh) 2005-06-15
NO20043735L (no) 2004-09-07
JP2005516994A (ja) 2005-06-09
EP2216025A2 (en) 2010-08-11
MXPA04007640A (es) 2004-11-10
WO2003066062A1 (en) 2003-08-14
TWI330177B (en) 2010-09-11
RU2353356C2 (ru) 2009-04-27
RU2004127132A (ru) 2005-06-10
GB0203061D0 (en) 2002-03-27

Similar Documents

Publication Publication Date Title
JP4775259B2 (ja) アニリン誘導体
SK25799A3 (en) Heterocyclic metalloprotease inhibitors
US20070093492A1 (en) Pyrrolidine derivatives
BRPI0709984A2 (pt) inibidores de enzima
WO2000066104A9 (en) Ace-2 inhibiting compounds and methods of use thereof
CZ184099A3 (cs) Sloučenina, farmaceutický prostředek a způsob prevence nebo léčby
CA2126687A1 (en) Substituted phosphinic acid-containing peptidyl derivatives as antidegenerative agents
WO2007103584A2 (en) Polyamides for treating human papilloma virus
US20070293473A1 (en) Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
JP2002527350A (ja) 発作を治療するのに有用なアミノ酸誘導体
HK1145139A (en) Use of acylaminoalkenylene-amide derivatives in irritable bowel syndrome and functional dyspepsia
CZ20032341A3 (cs) Použití antagonistů GAL3 receptoru pro léčbu deprese a/nebo úzkosti
JPH10511931A (ja) 非インシュリン依存性糖尿病の患者において胃空腹を抑制する1,5−ベンゾジアゼピン誘導体の使用
WO2019028270A1 (en) MATERIALS AND METHODS FOR DELETING AND / OR TREATING BONE-RELATED DISEASES AND SYMPTOMS
WO2020063388A1 (zh) 取代的5-氧代吡咯烷类衍生物及其制备方法和应用
US20050038034A1 (en) Pharmaceutical formulations comprising N,N'-disubstituted piperazine compounds
HK1077749B (en) Use of acylaminoalkenylene-amide derivatives in functional motility disorders of the viscera
JPH11246437A (ja) 消化管粘膜保護剤
RU2700595C1 (ru) Производное 3,6,9-триазатрициклотетрадекана и его применение для лечения депрессии
AU2004283038B2 (en) Use of neurokinin antagonists in the treatment of urinary incontinence
WO2001085696A1 (en) Butenoic acids derivatives and their use in the treatment of rhinitis
WO2004037266A1 (en) Compounds for the treatment of cough
JPH11286454A (ja) 虚血性脳血管障害の治療剤
JPH08503696A (ja) ウレイドアセトアミド誘導体類、それらの調製およびそれらを含む薬物
JPH0867632A (ja) 中性メタロエンドペプチダーゼ阻害剤

Legal Events

Date Code Title Description
EEER Examination request
FZDE Discontinued

Effective date: 20130207